Celebrex (celecoxib), the first COX-2 selective NSAID to hit the market
You're going to hear a lot about Celebrex (celecoxib), the first COX-2 selective NSAID to hit the market.
It'll be co-promoted by Searle and Pfizer.
Celebrex is approved for osteo- and rheumatoid arthritis. It's as effective as other NSAIDs for joint pain and swelling.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote